Skip to main content

Table 3 All grade (left column) and grade 3/4 (right column) treatment-related toxicities at final analysis (n = 43)

From: Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial)

Toxicity

All grade

Grade 3-4

non-hematological

  Fatigue

32.4%

0.1%*

  Nausea

8.0%

0%

  Vomiting

5.0%

0%

  Diarrhea

10.5%

0.1%*

  Mucositis

4.5%

0.1%*

  Sensorial neuropathy

2.4%

0%

hematological

  Anemia

44.0%

0.1%*

  Leukopenia

3.2%

0%

  Neutropenia

4.0%

0.1%*

  1. *Rounded to 0.1%.